It occurs in patients with ascites in the absence of recognized, secondary causes such as bowel perforation or intra-abdominal abscess; it’s noted in patients with cirrhosis and poor hepatic synthetic function.
The bacteria isolated from the ascitic fluid are those of the normal intestinal flora; 92% are monomicrobial (G negatives in 2/3; E. coli 50%,followed by Klebsiella and other Gram negatives; G + [25%, with streptococcal sp the most common]; anaerobic is rare). Impaired activity of the RES, decreased serum and ascitic C levels, and a low ascitic protein level are some of the mechanisms responsible for the entrance of enteral organisms into the ascitic fluid. Portal hypertension increases bacterial translocation to the lymphatic system and portal vein; the mechanisms responsible for this action are bacterial overgrowth due to impaired gastrintestinal transit, impaired host defense, or, most likely, morphologic and functional damage to the bowel mucosa. Impaired peripheral clearance of bacteria has also been demonstrated in patients with cirrhosis; in these ones, bacteria persist longer in the circulation and eventually gain access to the ascitic fluid as a result of decreased opsonic activity in serum and other neutrophil defects including chemotaxis. Thus, primary bacteremia in conjunction with secondary seeding of the ascitic fluid is the most likely explanation for the development of this disease.
An ultrasound should be done for detection and diagnostic aspiration of ascitic fluid. Fever and abdominal pain are common; onset or worsening of hepatic encephalopathy, rebound tenderness, and decreased bowel sounds have a varied frequency; subtle clinical findings such as mild hepatic encephalopathy, diarrhea, back pain, hypothermia, and refractoriness to diuretics are observed. It may be entirely asymptomatic (10%). But this disease should be considered in patients with ascites in whom there’s clinical deterioration, either in the presence or in the absence of peritoneal signs. Gram staining of ascitic fluid may help identify peritonitis due to gut perforation, but it infrequently detects bacteria in SBP. Special smears and cultures for TB are reserved for specific clinical situations, such as those in which a high fluid cell count has a predominance of lymphocytes. The PMN count in ascitic fluid is the best predictor of SBP; count > 500/mm3 has a sensitivity of 80% and a specificity of 98%, and you can consider SBP even in the absence of clinical signs and symptoms of peritonitis; a cell count < 250/mm3, in the setting of sterile fluid, rules out SBP. For bacterial cultures, 10 ml of ascitic fluid should be inoculated at the bedside in blood-culture bottles.
In an initial specimen of ascitic fluid, a leukocyte count greater than 10.000/mm3, a protein concentration > 1 g/dl, and the finding of polymicrobials, particularly in the setting of anaerobic bacteria or fungi, raise suspicion of secondary rather than primary peritonitis. If, after 48 hours of antibiotic, a diagnostic paracentesis shows an increase in PMN, Rx, TC, or water-soluble contrast studies of the upper and lower GIT must be performed to exclude bowel perforation or intra-abdominal abscess; it’s important because secondary one is best treated surgically.
Mortality (35%); factors associated with a poor outcome: BT > 8 mg/dl, albumin < 2,5 g/dl, creatinine > 2,1 mg/dl, hepatic encephalopathy, hepatorenal syndrome and upper GI bleeding (all indicators of poor liver function). After an initial episode of SBP, the probability of a recurrence at 1 year is of 70%, but in most patients the severity of the liver disease dictate the prognosis; thus, in general, they’re candidates for liver transplantation.
Cefotaxima, 2 g, EV, 8/8 hours, for 5 days, is the drug of choice, and have a cure of at least 85%; repeat paracentesis 48 hours after therapy has been initiated to confirm that cell counts have decreased.